Vismodegib: the Proof of Concept in Basal Cell Carcinoma

Vismodegib: the Proof of Concept in Basal Cell Carcinoma

Bibliographic Details
Main Authors:	Narjiss Berrada, Siham Lkhoyali, Hind Mrabti, Hassan Errihani
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-06-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://www.la-press.com/vismodegib-the-proof-of-concept-in-basal-cell-carcinoma-article-a4236

Similar Items

Treatment of Locally Advanced Basal Cell Carcinomas with Vismodegib
by: Luis Mastronardi, MD, et al.
Published: (2021-10-01)

Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib
by: Maxwell G. Su, et al.
Published: (2020-09-01)

Patient with metatypical metastatic Basal Cell Carcinoma treated with Vismodegib
by: D. Amarillo, et al.
Published: (2024-01-01)

Basal cell carcinoma: multimodal treatment and the role of neoadjuvant vismodegib
by: Pedro Carvalho Martins, et al.
Published: (2019-10-01)

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib
by: Batty N, et al.
Published: (2012-08-01)

Transformation of facial basal cell carcinoma to squamous cell carcinoma following vismodegib
by: Dustin A. Silverman, et al.
Published: (2021-09-01)

Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face
by: Alec M. Block, et al.
Published: (2015-01-01)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
by: Macha MA, et al.
Published: (2013-07-01)

Granulation tissue masquerading as basal cell carcinoma after treatment with vismodegib
by: Jayson Miedema, MD, et al.
Published: (2018-01-01)

Giant morphea-form basal cell carcinoma of the umbilicus: Successful debulking with vismodegib
by: Mariana Orduz Robledo, et al.
Published: (2018-05-01)

Metastatic giant basal cell carcinoma: a case report
by: Bellahammou Khadija, et al.
Published: (2016-06-01)

A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
by: Dawn Odom, et al.
Published: (2017-01-01)

Complete pathologic clearance with vismodegib in advanced basal cell carcinoma of the scalp with cranial invasion
by: Joseph Dodson, et al.
Published: (2022-12-01)

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
by: Antonio J García Ruiz, et al.
Published: (2022-07-01)

Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma
by: Raymond Zhao, BS, et al.
Published: (2022-10-01)

Basal cell cancer treatment. Therapeutic experience with vismodegib therapy
by: N. N. Petenko, et al.
Published: (2018-07-01)

Exploring vismodegib: A non-surgical breakthrough in the management of advanced periocular basal cell carcinoma
by: Georgios Lavasidis, et al.
Published: (2024-01-01)

Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib
by: Jaeyoung Yoon, MD, PhD, et al.
Published: (2018-01-01)

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
by: Apalla Z, et al.
Published: (2017-05-01)

Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
by: Glen J. Weiss, et al.
Published: (2011-12-01)

Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study
by: Mario Valenti, et al.
Published: (2025-02-01)

Vismodegib for the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study
by: Concetta Laliscia, et al.
Published: (2019-12-01)

Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series
by: Raquel Wescott, et al.
Published: (2023-10-01)

Gorlin Syndrome: Sequential Digital Dermoscopy of Palpebral Basal Cell Carcinomas in a Patient Treated With Vismodegib
by: Luis Mena-Vergara, et al.
Published: (2022-02-01)

SMO (SMOOTHENED TRANSMEMBRANE PROTEIN) INHIBITORS (VISMODEGIB) IN TREATMENT OF BASAL CELL CARCINOMA (BCC) OF OCULAR ADNEXA
by: Georgi Balchev, et al.
Published: (2020-04-01)

Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases
by: Kai Yuen Wong, MA, MRCS, et al.
Published: (2017-07-01)

Neoadjuvant Vismodegib plus Mohs surgery for locally advanced periocular basal cell carcinoma. Real world scenario
by: A. Gonzalez, et al.
Published: (2024-01-01)

Surgical Debulking Modifies Notch Signaling and May Improve Vismodegib Effectiveness for Locally Advanced Basal Cell Carcinoma
by: Natella Maglakelidze, et al.
Published: (2024-09-01)

A Non-interventional Study on Vismodegib for Basal Cell Carcinoma With A Treat-To-Target Regimen In Swedish Patients
by: Niels Bendsöe, et al.
Published: (2023-04-01)

Vismodegib for treatment of periocular basal cell carcinoma – 6-year experience from a tertiary cancer center,
by: Catarina Xavier, et al.
Published: (2022-01-01)

[Translated article] Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors
by: J. Kurnia Wijaya, et al.
Published: (2022-05-01)

Characterization of intractable diarrhea resulting from vismodegib treatment for basal cell nevus syndrome
by: Ashmi Patel, MS, et al.
Published: (2023-01-01)

Upfront Radiotherapy with Concurrent and Adjuvant Vismodegib Is Effective and Well-Tolerated in a Patient with Advanced, Multifocal Basal Cell Carcinoma
by: Abigail I. Franco, et al.
Published: (2018-01-01)

Tolerance of sonidegib after intolerance of vismodegib—Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome)
by: Federico Venturi, et al.
Published: (2023-10-01)

Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis
by: Maria Chiara Tronconi, et al.
Published: (2020-11-01)

Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib‐resistance
by: Silpa Gampala, et al.
Published: (2021-06-01)

Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy
by: Chalette Lambert-Swainston, et al.
Published: (2025-01-01)

[Translated article] Multimodal Therapy With Vismodegib and Radiotherapy in the Treatment of Locally Advanced Basal Cell Carcinoma: A Series of 4 Cases
by: L. Pulido Prieto, et al.
Published: (2023-03-01)

Role of Vismodegib in the Treatment of Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Single Latin American Institution Experience
by: Luis Mastronardi, MD
Published: (2022-10-01)

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
by: Aleksandar Sekulic, et al.
Published: (2017-05-01)